Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000939767-17-000120
Filing Date
2017-05-30
Accepted
2017-05-30 19:55:37
Documents
1
Period of Report
2017-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_149618852186498.html 4/A  
1 FORM 4/A wf-form4a_149618852186498.xml 4/A 7430
  Complete submission text file 0000939767-17-000120.txt   8980
Mailing Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 3 SOMERSET DRIVE SOUTH GREAT NECK NY 11020
Business Address
PAPADOPOULOS STELIOS (Reporting) CIK: 0001202098 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-30235 | Film No.: 17879225